Antibody-negative neuromyelitis optica with heavy B-cell infiltration

被引:1
|
作者
Blackburn, Daniel [1 ]
Highley, John Robin [2 ]
Wharton, Steve [2 ]
Romanowski, Charles [1 ]
Bowen, John [1 ]
Sharrack, Basil [1 ]
机构
[1] Univ Sheffield, Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Sheffield, Sch Med, Dept Neurosci, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England
关键词
Neuromyelitis optica; B lymphocytes; MULTIPLE-SCLEROSIS; NMO-IGG; RITUXIMAB; DISEASE;
D O I
10.1111/j.1600-0463.2009.02525.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There are several distinct clinical phenotypes of inflammatory demyelinating diseases of the central nervous system. In classical multiple sclerosis (MS) there are varied pathological patterns, possibly with differences in pathogenesis. Neuromyelitis optica (NMO) is often associated with a specific antibody, suggesting a distinct pathogenesis. We report a case of a young Caucasian male who presented with right hemiparesis secondary to a left fronto-parietal inflammatory brain lesion, which improved over years leaving minimal deficit. Seventeen years later he re-presented with a progressive tetraparesis secondary to cervical myelitis that did not respond to treatment. The NMO antibody was not detected and neuropathological examination was unusual with evidence of a persistent B-cell inflammatory response in the cord. Although having some of the clinical features of NMO, this case presented novel clinico-pathological features that do not easily fit into current MS subtypes.
引用
收藏
页码:768 / 772
页数:5
相关论文
共 50 条
  • [1] DIFFERENCES IN DISEASE PATTERNS BETWEEN AQUAPORIN-4 ANTIBODY-POSITIVE AND ANTIBODY-NEGATIVE PATIENTS WITH NEUROMYELITIS OPTICA
    Kim, S.
    Traboulsee, T.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 148 - 148
  • [2] Aquaporin-4 antibody-negative neuromyelitis optica Distinct assay sensitivity-dependent entity
    Marignier, Romain
    Bernard-Valnet, Raphael
    Giraudon, Pascale
    Collongues, Nicolas
    Papeix, Caroline
    Zephir, Helene
    Cavillon, Gaelle
    Rogemond, Veronique
    Casey, Romain
    Frangoulis, Bernard
    De Seze, Jerome
    Vukusic, Sandra
    Honnorat, Jerome
    Confavreux, Christian
    [J]. NEUROLOGY, 2013, 80 (24) : 2194 - 2200
  • [3] Differences in Disease Patterns between Aquaporin-4 Antibody-Positive and Antibody-Negative Patients with Neuromyelitis Optica
    Kim, Rachel
    Kuan, Annie
    Fujihara, Kazuo
    Takahaski, Toshiyuki
    Traboulsee, Anthony
    [J]. NEUROLOGY, 2013, 80
  • [4] Severe Relapse Despite B-Cell Depletion in Neuromyelitis Optica
    Riley, Claire
    Tullman, Mark
    [J]. NEUROLOGY, 2010, 74 (09) : A171 - A171
  • [5] B-CELL ACTIVATING FACTOR OF THE TNF FAMILY IS UPREGULATED IN NEUROMYELITIS OPTICA
    Okada, Kazumasa
    Matsushita, Takuya
    Kira, Jun-ichi
    Tsuji, Sadatoshi
    [J]. NEUROLOGY, 2010, 74 (02) : 177 - 178
  • [6] Clinical, radiological and quantitative imaging analysis reveals distinct subgroups in the antibody-negative neuromyelitis optica/multiple sclerosis overlap cohort
    Jurynczyk, M.
    Klimiec-Moskal, E.
    Kong, Y.
    Hurley, S.
    Messina, S.
    Yeo, T.
    Jenkinson, M.
    Leite, M.
    Palace, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 443 - 443
  • [7] Effects of B-cell depletion on T-cell subsets and function in neuromyelitis optica
    Genain, Claude P.
    Islar, Janeen
    Gardell, Jennifer
    Ross, Michael
    Korynyeya, Elena
    Cree, Bruce A.
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S11 - S11
  • [8] If initial repeated neuromyelitis optica antibody is negative, do we still consider neuromyelitis optica spectrum disorder?
    Thakre, Mona Chetan
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP7 - NP7
  • [9] B-cell depletion therapy using rituximab in neuromyelitis optica spectrum disorders
    Kim, H. J.
    Kim, W.
    Park, M. S.
    Ha, C. K.
    Jung, I. J.
    Lee, K. I.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S253 - S254